Aspen Global, Inc.

301 GBS Plaza cnr La Salette and Royal Roads,
Grand Bay,
Mauritius,
230 269 1111

South African-based Aspen is a supplier of branded and generic pharmaceuticals in more than 150 countries across the world and of consumer and nutritional products in selected territories. Aspen has production capabilities for a wide variety of product types including tablets, capsules, eye drops, injectable products (including lyophilized vials), oral contraceptives, form-filled seals, suppositories, liquids, creams, ointments, infant nutritional products, and specialist active pharmaceutical ingredients.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.2/yr) # - 1 - - - - 1
vol $1.1B $1.1B
Sell (0.2/yr) # - - 1 - - - 1
vol $51M $51M
  2

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest GSK's Arixtra, Fraxiparine brands
$1.1B (2013-09-30)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest OTC Products
$51M (2014-02-28)

According to our data here at Mergr, Aspen Global has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.

Aspen Global’s largest acquisition to date was in 2013, when it acquired GSK s Arixtra Fraxiparine brands for $1.1B. It’s largest disclosed sale occurred in 2014, when it sold OTC Products to Perrigo Company for $51M. The Company’s most targeted sectors include medical products (100%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 420 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 24 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Aspen Global’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.